fanta.bio Sample: CNhs12004
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
16789 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1191 / 11635 (10.2%) | 286 / 116350 (0.2%) | −324.0 | −324.0 | 41.64 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1701 / 11635 (14.6%) | 525 / 116350 (0.5%) | −324.0 | −324.0 | 32.40 |
| HIF1A SRX11007095 | HK-2 Kidney | 2032 / 11635 (17.5%) | 708 / 116350 (0.6%) | −324.0 | −324.0 | 28.70 |
| TP53 SRX19538279 | Osteoblasts Bone | 512 / 11635 (4.4%) | 197 / 116350 (0.2%) | −324.0 | −324.0 | 25.99 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1427 / 11635 (12.3%) | 614 / 116350 (0.5%) | −324.0 | −324.0 | 23.24 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1917 / 11635 (16.5%) | 879 / 116350 (0.8%) | −324.0 | −324.0 | 21.81 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1972 / 11635 (16.9%) | 929 / 116350 (0.8%) | −324.0 | −324.0 | 21.23 |
| SCML2 SRX644728 | 293 Kidney | 1148 / 11635 (9.9%) | 583 / 116350 (0.5%) | −324.0 | −324.0 | 19.69 |
| FOXP1 SRX736067 | LNCAP Prostate | 1527 / 11635 (13.1%) | 876 / 116350 (0.8%) | −324.0 | −324.0 | 17.43 |
| MYH11 SRX265221 | ME-1 Blood | 713 / 11635 (6.1%) | 475 / 116350 (0.4%) | −324.0 | −324.0 | 15.01 |
| BRD4 SRX9419935 | BT-474 Breast | 2874 / 11635 (24.7%) | 2103 / 116350 (1.8%) | −324.0 | −324.0 | 13.67 |
| BRD4 SRX9419937 | BT-474 Breast | 2864 / 11635 (24.6%) | 2149 / 116350 (1.8%) | −324.0 | −324.0 | 13.33 |
| MED1 SRX9419944 | BT-474 Breast | 2793 / 11635 (24.0%) | 2112 / 116350 (1.8%) | −324.0 | −324.0 | 13.22 |
| MED1 SRX9419945 | BT-474 Breast | 2837 / 11635 (24.4%) | 2149 / 116350 (1.8%) | −324.0 | −324.0 | 13.20 |
| BRD4 SRX9419936 | BT-474 Breast | 2906 / 11635 (25.0%) | 2258 / 116350 (1.9%) | −324.0 | −324.0 | 12.87 |
| MED1 SRX9419946 | BT-474 Breast | 2900 / 11635 (24.9%) | 2268 / 116350 (1.9%) | −324.0 | −324.0 | 12.79 |
| MED1 SRX9419947 | BT-474 Breast | 2796 / 11635 (24.0%) | 2190 / 116350 (1.9%) | −324.0 | −324.0 | 12.77 |
| BRD4 SRX9419938 | BT-474 Breast | 2850 / 11635 (24.5%) | 2235 / 116350 (1.9%) | −324.0 | −324.0 | 12.75 |
| BRD4 SRX736201 | 90-8TL Neural | 4841 / 11635 (41.6%) | 4841 / 116350 (4.2%) | −324.0 | −324.0 | 10.00 |
| EZH2 SRX2146136 | LNCAP Prostate | 5903 / 11635 (50.7%) | 6039 / 116350 (5.2%) | −324.0 | −324.0 | 9.77 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1478 / 11635 (12.7%) | 1903 / 116350 (1.6%) | −324.0 | −324.0 | 7.77 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1236 / 11635 (10.6%) | 2484 / 116350 (2.1%) | −324.0 | −324.0 | 4.98 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1373 / 11635 (11.8%) | 3549 / 116350 (3.1%) | −324.0 | −324.0 | 3.87 |
| TP53 SRX19538268 | U2OS Bone | 413 / 11635 (3.5%) | 117 / 116350 (0.1%) | −317.6 | −314.4 | 35.30 |
| TP53 SRX19538274 | U2OS Bone | 412 / 11635 (3.5%) | 131 / 116350 (0.1%) | −308.3 | −305.2 | 31.45 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 618 / 11635 (5.3%) | 617 / 116350 (0.5%) | −304.3 | −301.2 | 10.02 |
| TP53 SRX19538276 | U2OS Bone | 408 / 11635 (3.5%) | 132 / 116350 (0.1%) | −304.0 | −300.9 | 30.91 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 414 / 11635 (3.6%) | 151 / 116350 (0.1%) | −299.1 | −296.0 | 27.42 |
| TP53 SRX19538280 | Osteoblasts Bone | 405 / 11635 (3.5%) | 147 / 116350 (0.1%) | −292.9 | −289.9 | 27.55 |
| PBX4 SRX2731658 | PC-3 Prostate | 522 / 11635 (4.5%) | 18121 / 116350 (15.6%) | −292.9 | −289.9 | 0.29 |
| IRF3 SRX11453858 | Hep G2 Liver | 327 / 11635 (2.8%) | 45 / 116350 (0.0%) | −285.8 | −282.8 | 72.67 |
| HIF1A SRX20663235 | HK-2 Kidney | 428 / 11635 (3.7%) | 212 / 116350 (0.2%) | −282.3 | −279.3 | 20.19 |
| AGO2 SRX4708039 | Hep G2 Liver | 1567 / 11635 (13.5%) | 5181 / 116350 (4.5%) | −280.1 | −277.1 | 3.02 |
| TP53 SRX19538267 | U2OS Bone | 362 / 11635 (3.1%) | 111 / 116350 (0.1%) | −273.1 | −270.1 | 32.61 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 585 / 11635 (5.0%) | 654 / 116350 (0.6%) | −270.4 | −267.4 | 8.94 |
| TP53 SRX19538275 | U2OS Bone | 371 / 11635 (3.2%) | 131 / 116350 (0.1%) | −270.2 | −267.2 | 28.32 |
| TP53 SRX19538281 | Osteoblasts Bone | 413 / 11635 (3.5%) | 210 / 116350 (0.2%) | −270.0 | −267.0 | 19.67 |
| TP53 SRX19538273 | U2OS Bone | 356 / 11635 (3.1%) | 111 / 116350 (0.1%) | −267.5 | −264.6 | 32.07 |
| TP53 SRX19538269 | U2OS Bone | 448 / 11635 (3.9%) | 293 / 116350 (0.3%) | −267.2 | −264.3 | 15.29 |
| TP53 SRX19538270 | U2OS Bone | 419 / 11635 (3.6%) | 294 / 116350 (0.3%) | −242.8 | −239.8 | 14.25 |
| IRF3 SRX11453861 | Hep G2 Liver | 285 / 11635 (2.4%) | 48 / 116350 (0.0%) | −241.7 | −238.8 | 59.38 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 555 / 11635 (4.8%) | 687 / 116350 (0.6%) | −241.3 | −238.4 | 8.08 |
| BRD4 SRX736204 | 90-8TL Neural | 855 / 11635 (7.3%) | 1915 / 116350 (1.6%) | −235.6 | −232.7 | 4.46 |
| FOS SRX150477 | MCF 10A Breast | 352 / 11635 (3.0%) | 13532 / 116350 (11.6%) | −233.9 | −231.0 | 0.26 |
| YAP1 SRX757325 | H2052 Lung | 384 / 11635 (3.3%) | 13961 / 116350 (12.0%) | −229.8 | −226.9 | 0.28 |
| FOS SRX150478 | MCF 10A Breast | 384 / 11635 (3.3%) | 13835 / 116350 (11.9%) | −225.5 | −222.7 | 0.28 |
| 5-mC SRX882968 | LNCAP Prostate | 2222 / 11635 (19.1%) | 10372 / 116350 (8.9%) | −223.7 | −220.9 | 2.14 |
| RUNX1 SRX2513054 | 293 Kidney | 2488 / 11635 (21.4%) | 12334 / 116350 (10.6%) | −221.8 | −219.0 | 2.02 |
| 5-mC SRX882970 | LNCAP Prostate | 2234 / 11635 (19.2%) | 10502 / 116350 (9.0%) | −221.6 | −218.8 | 2.13 |
| TP53 SRX19538282 | Osteoblasts Bone | 354 / 11635 (3.0%) | 223 / 116350 (0.2%) | −214.0 | −211.2 | 15.87 |
| TP53 SRX19538271 | U2OS Bone | 567 / 11635 (4.9%) | 874 / 116350 (0.8%) | −212.8 | −209.9 | 6.49 |
| YAP1 SRX757326 | H2052 Lung | 327 / 11635 (2.8%) | 12447 / 116350 (10.7%) | −211.8 | −209.0 | 0.26 |
| Epitope tags SRX10549776 | K-562 Blood | 1133 / 11635 (9.7%) | 3613 / 116350 (3.1%) | −209.0 | −206.2 | 3.14 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1642 / 11635 (14.1%) | 6717 / 116350 (5.8%) | −208.7 | −205.9 | 2.44 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 358 / 11635 (3.1%) | 12784 / 116350 (11.0%) | −205.4 | −202.7 | 0.28 |
| AGO2 SRX6783957 | Hep G2 Liver | 1040 / 11635 (8.9%) | 3152 / 116350 (2.7%) | −204.7 | −201.9 | 3.30 |
| KAT6A SRX20971022 | Fibroblasts Others | 249 / 11635 (2.1%) | 53 / 116350 (0.0%) | −202.8 | −200.0 | 46.98 |
| AR SRX10820653 | LNCAP Prostate | 307 / 11635 (2.6%) | 151 / 116350 (0.1%) | −202.7 | −199.9 | 20.33 |
| BRD1 SRX286203 | RKO Digestive tract | 976 / 11635 (8.4%) | 2833 / 116350 (2.4%) | −202.5 | −199.7 | 3.45 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1133 / 11635 (9.7%) | 3729 / 116350 (3.2%) | −199.8 | −197.0 | 3.04 |
| FOS SRX4192880 | MCF 10A Breast | 266 / 11635 (2.3%) | 10968 / 116350 (9.4%) | −198.3 | −195.6 | 0.24 |
| KAT7 SRX101303 | RKO Digestive tract | 1080 / 11635 (9.3%) | 3508 / 116350 (3.0%) | −193.8 | −191.0 | 3.08 |
| 5-mC SRX882965 | LNCAP Prostate | 1805 / 11635 (15.5%) | 8087 / 116350 (7.0%) | −193.7 | −191.0 | 2.23 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 707 / 11635 (6.1%) | 1603 / 116350 (1.4%) | −191.6 | −188.9 | 4.41 |
| CIC SRX13262055 | Astrocytes Neural | 2293 / 11635 (19.7%) | 11613 / 116350 (10.0%) | −191.5 | −188.8 | 1.97 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1378 / 11635 (11.8%) | 5328 / 116350 (4.6%) | −191.1 | −188.4 | 2.59 |
| AGO2 SRX6783958 | Hep G2 Liver | 992 / 11635 (8.5%) | 3069 / 116350 (2.6%) | −189.6 | −186.9 | 3.23 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 956 / 11635 (8.2%) | 2892 / 116350 (2.5%) | −188.0 | −185.3 | 3.31 |
| FOXA1 SRX4815198 | MCF-7 Breast | 630 / 11635 (5.4%) | 16487 / 116350 (14.2%) | −187.7 | −185.0 | 0.38 |
| AR SRX10820651 | LNCAP Prostate | 322 / 11635 (2.8%) | 229 / 116350 (0.2%) | −185.3 | −182.7 | 14.06 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 252 / 11635 (2.2%) | 86 / 116350 (0.1%) | −185.0 | −182.4 | 29.30 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 402 / 11635 (3.5%) | 458 / 116350 (0.4%) | −183.2 | −180.5 | 8.78 |
| BRPF3 SRX796085 | RKO Digestive tract | 869 / 11635 (7.5%) | 2506 / 116350 (2.2%) | −181.0 | −178.4 | 3.47 |
| TP53 SRX396254 | Fibroblasts Others | 733 / 11635 (6.3%) | 1823 / 116350 (1.6%) | −180.6 | −177.9 | 4.02 |
| BRPF3 SRX796084 | RKO Digestive tract | 1169 / 11635 (10.0%) | 4252 / 116350 (3.7%) | −177.5 | −174.9 | 2.75 |
| BRPF3 SRX796086 | RKO Digestive tract | 1130 / 11635 (9.7%) | 4044 / 116350 (3.5%) | −175.9 | −173.2 | 2.79 |
| SREBF2 SRX5359048 | HCC70 Breast | 1325 / 11635 (11.4%) | 5265 / 116350 (4.5%) | −174.7 | −172.1 | 2.52 |
| FOXA1 SRX176862 | MCF-7 Breast | 221 / 11635 (1.9%) | 9448 / 116350 (8.1%) | −174.3 | −171.7 | 0.23 |
| TP53 SRX19538272 | U2OS Bone | 486 / 11635 (4.2%) | 810 / 116350 (0.7%) | −171.7 | −169.1 | 6.00 |
| FOXA1 SRX4815197 | MCF-7 Breast | 472 / 11635 (4.1%) | 13515 / 116350 (11.6%) | −170.4 | −167.8 | 0.35 |
| FOS SRX150517 | MCF 10A Breast | 316 / 11635 (2.7%) | 10943 / 116350 (9.4%) | −168.6 | −166.0 | 0.29 |
| STAT5B SRX831881 | CD8+ T cells Blood | 242 / 11635 (2.1%) | 103 / 116350 (0.1%) | −167.2 | −164.6 | 23.50 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1259 / 11635 (10.8%) | 4975 / 116350 (4.3%) | −167.1 | −164.5 | 2.53 |
| FOS SRX150476 | MCF 10A Breast | 324 / 11635 (2.8%) | 10996 / 116350 (9.5%) | −166.1 | −163.5 | 0.29 |
| ESR1 SRX371478 | MCF-7 Breast | 228 / 11635 (2.0%) | 9302 / 116350 (8.0%) | −165.1 | −162.5 | 0.25 |
| JUNB SRX8488088 | SUM 229PE Breast | 369 / 11635 (3.2%) | 11679 / 116350 (10.0%) | −164.2 | −161.6 | 0.32 |
| ESR1 SRX7624157 | MCF-7 Breast | 517 / 11635 (4.4%) | 13974 / 116350 (12.0%) | −163.6 | −161.1 | 0.37 |
| TRP47 SRX4548329 | THP-1 Blood | 1937 / 11635 (16.6%) | 9680 / 116350 (8.3%) | −163.6 | −161.0 | 2.00 |
| FOXA1 SRX176863 | MCF-7 Breast | 215 / 11635 (1.8%) | 9012 / 116350 (7.7%) | −163.3 | −160.8 | 0.24 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1467 / 11635 (12.6%) | 6411 / 116350 (5.5%) | −162.7 | −160.1 | 2.29 |
| FOXA1 SRX3931044 | MCF-7 Breast | 425 / 11635 (3.7%) | 12504 / 116350 (10.7%) | −162.1 | −159.6 | 0.34 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1374 / 11635 (11.8%) | 5826 / 116350 (5.0%) | −160.8 | −158.3 | 2.36 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 475 / 11635 (4.1%) | 13223 / 116350 (11.4%) | −160.5 | −158.0 | 0.36 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1326 / 11635 (11.4%) | 5530 / 116350 (4.8%) | −160.0 | −157.4 | 2.40 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1440 / 11635 (12.4%) | 6306 / 116350 (5.4%) | −158.8 | −156.2 | 2.28 |
| GATA3 SRX190239 | MCF-7 Breast | 276 / 11635 (2.4%) | 9953 / 116350 (8.6%) | −158.7 | −156.2 | 0.28 |
| FOXA1 SRX1161177 | MCF-7 Breast | 176 / 11635 (1.5%) | 8152 / 116350 (7.0%) | −158.6 | −156.1 | 0.22 |
| BMI1 SRX7196721 | SF8628 Neural | 1301 / 11635 (11.2%) | 5400 / 116350 (4.6%) | −158.1 | −155.5 | 2.41 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 708 / 11635 (6.1%) | 16554 / 116350 (14.2%) | −157.8 | −155.3 | 0.43 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 230 / 11635 (2.0%) | 9114 / 116350 (7.8%) | −157.6 | −155.1 | 0.25 |
| ESR1 SRX7624156 | MCF-7 Breast | 313 / 11635 (2.7%) | 10488 / 116350 (9.0%) | −155.9 | −153.3 | 0.30 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 125 / 11635 (1.1%) | 7059 / 116350 (6.1%) | −155.6 | −153.1 | 0.18 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 965 / 11635 (8.3%) | 3360 / 116350 (2.9%) | −155.5 | −153.0 | 2.87 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 502 / 11635 (4.3%) | 982 / 116350 (0.8%) | −155.4 | −152.9 | 5.11 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1190 / 11635 (10.2%) | 4748 / 116350 (4.1%) | −154.8 | −152.3 | 2.51 |
| ING5 SRX286202 | RKO Digestive tract | 996 / 11635 (8.6%) | 3565 / 116350 (3.1%) | −154.0 | −151.5 | 2.79 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 224 / 11635 (1.9%) | 8898 / 116350 (7.6%) | −154.0 | −151.5 | 0.25 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1373 / 11635 (11.8%) | 5962 / 116350 (5.1%) | −153.3 | −150.9 | 2.30 |
| AR SRX1067071 | LHSAR Prostate | 408 / 11635 (3.5%) | 11931 / 116350 (10.3%) | −153.0 | −150.5 | 0.34 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 341 / 11635 (2.9%) | 10849 / 116350 (9.3%) | −152.7 | −150.3 | 0.31 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 712 / 11635 (6.1%) | 16381 / 116350 (14.1%) | −151.7 | −149.2 | 0.43 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 380 / 11635 (3.3%) | 537 / 116350 (0.5%) | −151.1 | −148.6 | 7.08 |
| BMI1 SRX644729 | 293 Kidney | 219 / 11635 (1.9%) | 94 / 116350 (0.1%) | −150.9 | −148.5 | 23.30 |
| ESR1 SRX4367193 | MCF-7 Breast | 700 / 11635 (6.0%) | 16180 / 116350 (13.9%) | −150.8 | −148.4 | 0.43 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 226 / 11635 (1.9%) | 8816 / 116350 (7.6%) | −150.2 | −147.7 | 0.26 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 543 / 11635 (4.7%) | 1204 / 116350 (1.0%) | −149.8 | −147.3 | 4.51 |
| JUN SRX17561461 | LPS141 Adipocyte | 283 / 11635 (2.4%) | 9785 / 116350 (8.4%) | −149.5 | −147.1 | 0.29 |
| ESR1 SRX371469 | MCF-7 Breast | 198 / 11635 (1.7%) | 8285 / 116350 (7.1%) | −149.3 | −146.8 | 0.24 |
| FOXA1 SRX371481 | MCF-7 Breast | 206 / 11635 (1.8%) | 8388 / 116350 (7.2%) | −147.8 | −145.4 | 0.25 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 414 / 11635 (3.6%) | 680 / 116350 (0.6%) | −147.7 | −145.3 | 6.09 |
| ESR1 SRX371479 | MCF-7 Breast | 170 / 11635 (1.5%) | 7706 / 116350 (6.6%) | −147.4 | −145.0 | 0.22 |
| MECOM SRX23677885 | HNT-34 Blood | 1308 / 11635 (11.2%) | 5650 / 116350 (4.9%) | −147.2 | −144.8 | 2.32 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 291 / 11635 (2.5%) | 9840 / 116350 (8.5%) | −147.1 | −144.7 | 0.30 |
| MECOM SRX23677897 | HNT-34 Blood | 1512 / 11635 (13.0%) | 7040 / 116350 (6.1%) | −146.9 | −144.5 | 2.15 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 462 / 11635 (4.0%) | 12554 / 116350 (10.8%) | −146.9 | −144.4 | 0.37 |
| ESR1 SRX20282961 | MCF-7 Breast | 256 / 11635 (2.2%) | 9230 / 116350 (7.9%) | −146.6 | −144.2 | 0.28 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 176 / 11635 (1.5%) | 7798 / 116350 (6.7%) | −146.6 | −144.2 | 0.23 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 352 / 11635 (3.0%) | 10820 / 116350 (9.3%) | −146.4 | −144.0 | 0.33 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 259 / 11635 (2.2%) | 9274 / 116350 (8.0%) | −146.3 | −143.9 | 0.28 |
| FOXA1 SRX371482 | MCF-7 Breast | 297 / 11635 (2.6%) | 9915 / 116350 (8.5%) | −146.2 | −143.8 | 0.30 |
| MECOM SRX23677896 | HNT-34 Blood | 1558 / 11635 (13.4%) | 7385 / 116350 (6.3%) | −145.9 | −143.5 | 2.11 |
| SMARCA4 SRX5212366 | Mel270 Others | 261 / 11635 (2.2%) | 9285 / 116350 (8.0%) | −145.5 | −143.1 | 0.28 |
| FOS SRX4192879 | MCF 10A Breast | 222 / 11635 (1.9%) | 8600 / 116350 (7.4%) | −145.4 | −143.0 | 0.26 |
| MEAF6 DRX234811 | 293 Kidney | 1235 / 11635 (10.6%) | 5219 / 116350 (4.5%) | −144.6 | −142.2 | 2.37 |
| SMARCA4 SRX5212357 | Mel270 Others | 286 / 11635 (2.5%) | 9677 / 116350 (8.3%) | −144.6 | −142.2 | 0.30 |
| MECOM SRX23677884 | HNT-34 Blood | 1285 / 11635 (11.0%) | 5552 / 116350 (4.8%) | −144.4 | −142.0 | 2.31 |
| FOXA1 SRX371483 | MCF-7 Breast | 228 / 11635 (2.0%) | 8675 / 116350 (7.5%) | −144.3 | −142.0 | 0.26 |
| YAP1 SRX5718140 | 293 Kidney | 354 / 11635 (3.0%) | 10779 / 116350 (9.3%) | −144.1 | −141.7 | 0.33 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 186 / 11635 (1.6%) | 7907 / 116350 (6.8%) | −144.0 | −141.6 | 0.24 |
| SMARCA4 SRX5212362 | Mel270 Others | 356 / 11635 (3.1%) | 10784 / 116350 (9.3%) | −143.4 | −141.0 | 0.33 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 488 / 11635 (4.2%) | 1014 / 116350 (0.9%) | −143.0 | −140.7 | 4.81 |
| ESR1 SRX176861 | MCF-7 Breast | 349 / 11635 (3.0%) | 10657 / 116350 (9.2%) | −142.9 | −140.5 | 0.33 |
| GATA3 SRX190194 | SK-N-SH Neural | 513 / 11635 (4.4%) | 13182 / 116350 (11.3%) | −142.9 | −140.5 | 0.39 |
| AR SRX1067070 | LHSAR Prostate | 541 / 11635 (4.6%) | 13562 / 116350 (11.7%) | −141.9 | −139.6 | 0.40 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1319 / 11635 (11.3%) | 5840 / 116350 (5.0%) | −141.3 | −138.9 | 2.26 |
| MEAF6 DRX300417 | 293 Kidney | 1131 / 11635 (9.7%) | 4610 / 116350 (4.0%) | −141.1 | −138.7 | 2.45 |
| TLE3 SRX4815191 | MCF-7 Breast | 189 / 11635 (1.6%) | 7870 / 116350 (6.8%) | −141.0 | −138.6 | 0.24 |
| LEO1 SRX1873456 | SEM Blood | 1075 / 11635 (9.2%) | 4259 / 116350 (3.7%) | −140.7 | −138.3 | 2.52 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1313 / 11635 (11.3%) | 5815 / 116350 (5.0%) | −140.6 | −138.3 | 2.26 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 511 / 11635 (4.4%) | 13071 / 116350 (11.2%) | −140.5 | −138.2 | 0.39 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 459 / 11635 (3.9%) | 12276 / 116350 (10.6%) | −140.2 | −137.9 | 0.37 |
| FOXA1 SRX1161176 | MCF-7 Breast | 189 / 11635 (1.6%) | 7850 / 116350 (6.7%) | −140.2 | −137.9 | 0.24 |
| MITF SRX1555436 | 501A Epidermis | 1420 / 11635 (12.2%) | 6552 / 116350 (5.6%) | −140.2 | −137.8 | 2.17 |
| SMARCA4 SRX5212371 | Mel270 Others | 288 / 11635 (2.5%) | 9555 / 116350 (8.2%) | −139.7 | −137.4 | 0.30 |
| ESR1 SRX176860 | MCF-7 Breast | 355 / 11635 (3.1%) | 10633 / 116350 (9.1%) | −139.3 | −137.0 | 0.33 |
| ESR1 SRX371470 | ZR-75-1 Breast | 181 / 11635 (1.6%) | 7662 / 116350 (6.6%) | −138.9 | −136.6 | 0.24 |
| FOXA1 SRX371480 | MCF-7 Breast | 120 / 11635 (1.0%) | 6483 / 116350 (5.6%) | −138.9 | −136.5 | 0.19 |
| ESR1 SRX194569 | MCF-7 Breast | 210 / 11635 (1.8%) | 8177 / 116350 (7.0%) | −138.6 | −136.3 | 0.26 |
| ESR1 SRX20282960 | MCF-7 Breast | 237 / 11635 (2.0%) | 8651 / 116350 (7.4%) | −138.6 | −136.2 | 0.27 |
| ESR1 SRX371471 | ZR-75-1 Breast | 226 / 11635 (1.9%) | 8437 / 116350 (7.3%) | −137.8 | −135.5 | 0.27 |
| SMARCA2 SRX8119677 | MeT-5A Others | 346 / 11635 (3.0%) | 10432 / 116350 (9.0%) | −137.7 | −135.3 | 0.33 |
| JUNB SRX10119386 | MCF 10A Breast | 171 / 11635 (1.5%) | 7437 / 116350 (6.4%) | −137.5 | −135.2 | 0.23 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 313 / 11635 (2.7%) | 9893 / 116350 (8.5%) | −137.4 | −135.1 | 0.32 |
| GATA3 SRX176864 | MCF-7 Breast | 137 / 11635 (1.2%) | 6771 / 116350 (5.8%) | −137.1 | −134.8 | 0.20 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 175 / 11635 (1.5%) | 7485 / 116350 (6.4%) | −136.8 | −134.5 | 0.23 |
| RUNX1 SRX2014504 | Jurkat Blood | 1734 / 11635 (14.9%) | 8867 / 116350 (7.6%) | −136.7 | −134.4 | 1.96 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 270 / 11635 (2.3%) | 9147 / 116350 (7.9%) | −136.4 | −134.1 | 0.30 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 542 / 11635 (4.7%) | 13374 / 116350 (11.5%) | −136.4 | −134.1 | 0.41 |
| RELA SRX2207673 | HUVEC Cardiovascular | 810 / 11635 (7.0%) | 17130 / 116350 (14.7%) | −136.1 | −133.8 | 0.47 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 417 / 11635 (3.6%) | 11479 / 116350 (9.9%) | −135.8 | −133.5 | 0.36 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 719 / 11635 (6.2%) | 15859 / 116350 (13.6%) | −135.6 | −133.3 | 0.45 |
| KMT2A SRX2323891 | 293 Kidney | 732 / 11635 (6.3%) | 2305 / 116350 (2.0%) | −135.3 | −133.0 | 3.18 |
| JUNB SRX8488073 | SUM 229PE Breast | 408 / 11635 (3.5%) | 11324 / 116350 (9.7%) | −135.3 | −133.0 | 0.36 |
| SSRP1 SRX3436567 | HT-1080 Bone | 318 / 11635 (2.7%) | 406 / 116350 (0.3%) | −135.1 | −132.9 | 7.83 |
| GATA3 SRX5057632 | MCF-7 Breast | 117 / 11635 (1.0%) | 6318 / 116350 (5.4%) | −135.1 | −132.8 | 0.19 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 220 / 11635 (1.9%) | 8245 / 116350 (7.1%) | −135.0 | −132.7 | 0.27 |
| SS18 SRX3468047 | Fibroblasts Others | 567 / 11635 (4.9%) | 13680 / 116350 (11.8%) | −134.9 | −132.6 | 0.41 |
| FOXA1 SRX1161173 | MCF-7 Breast | 157 / 11635 (1.3%) | 7094 / 116350 (6.1%) | −134.8 | −132.5 | 0.22 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 354 / 11635 (3.0%) | 10467 / 116350 (9.0%) | −134.8 | −132.5 | 0.34 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 179 / 11635 (1.5%) | 7494 / 116350 (6.4%) | −134.5 | −132.2 | 0.24 |
| Epitope tags SRX10549778 | K-562 Blood | 833 / 11635 (7.2%) | 2891 / 116350 (2.5%) | −134.3 | −132.1 | 2.88 |
| ESR1 SRX371467 | MCF-7 Breast | 219 / 11635 (1.9%) | 8206 / 116350 (7.1%) | −134.3 | −132.0 | 0.27 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 182 / 11635 (1.6%) | 7535 / 116350 (6.5%) | −134.1 | −131.9 | 0.24 |
| ESR1 SRX194572 | MCF-7 Breast | 116 / 11635 (1.0%) | 6253 / 116350 (5.4%) | −133.6 | −131.4 | 0.19 |
| FOXA1 SRX1787653 | MCF-7 Breast | 157 / 11635 (1.3%) | 7053 / 116350 (6.1%) | −133.4 | −131.2 | 0.22 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 184 / 11635 (1.6%) | 7549 / 116350 (6.5%) | −133.4 | −131.1 | 0.24 |
| ESR1 SRX20282939 | MCF-7 Breast | 249 / 11635 (2.1%) | 8696 / 116350 (7.5%) | −133.4 | −131.1 | 0.29 |
| ESR1 SRX371476 | MCF-7 Breast | 149 / 11635 (1.3%) | 6897 / 116350 (5.9%) | −133.4 | −131.1 | 0.22 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1136 / 11635 (9.8%) | 4784 / 116350 (4.1%) | −133.3 | −131.1 | 2.37 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 181 / 11635 (1.6%) | 7484 / 116350 (6.4%) | −133.0 | −130.7 | 0.24 |
| FOXA1 SRX1161175 | MCF-7 Breast | 146 / 11635 (1.3%) | 6823 / 116350 (5.9%) | −132.9 | −130.6 | 0.21 |
| JUN SRX4192884 | MCF 10A Breast | 161 / 11635 (1.4%) | 7108 / 116350 (6.1%) | −132.8 | −130.5 | 0.23 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 665 / 11635 (5.7%) | 1973 / 116350 (1.7%) | −132.8 | −130.5 | 3.37 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 429 / 11635 (3.7%) | 11548 / 116350 (9.9%) | −132.5 | −130.3 | 0.37 |
| JUNB SRX4192882 | MCF 10A Breast | 152 / 11635 (1.3%) | 6927 / 116350 (6.0%) | −132.5 | −130.2 | 0.22 |
| CEBPB SRX150632 | HeLa Uterus | 512 / 11635 (4.4%) | 12778 / 116350 (11.0%) | −132.2 | −130.0 | 0.40 |
| JUNB SRX8488089 | SUM 229PE Breast | 206 / 11635 (1.8%) | 7906 / 116350 (6.8%) | −132.1 | −129.9 | 0.26 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 208 / 11635 (1.8%) | 7934 / 116350 (6.8%) | −131.8 | −129.6 | 0.26 |
| VGLL1 SRX24602130 | BT-20 Breast | 224 / 11635 (1.9%) | 8203 / 116350 (7.1%) | −131.5 | −129.3 | 0.27 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 192 / 11635 (1.7%) | 7618 / 116350 (6.5%) | −130.9 | −128.7 | 0.25 |
| ARID1A SRX5089376 | MCF-7 Breast | 175 / 11635 (1.5%) | 7286 / 116350 (6.3%) | −130.0 | −127.8 | 0.24 |
| ZFX SRX7805372 | 293 Kidney | 1124 / 11635 (9.7%) | 4767 / 116350 (4.1%) | −130.0 | −127.8 | 2.36 |
| ESR1 SRX371468 | MCF-7 Breast | 124 / 11635 (1.1%) | 6313 / 116350 (5.4%) | −130.0 | −127.7 | 0.20 |
| ESR1 SRX1531791 | MCF-7 Breast | 209 / 11635 (1.8%) | 7884 / 116350 (6.8%) | −129.7 | −127.5 | 0.27 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 436 / 11635 (3.7%) | 11549 / 116350 (9.9%) | −129.5 | −127.3 | 0.38 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1353 / 11635 (11.6%) | 6321 / 116350 (5.4%) | −129.4 | −127.2 | 2.14 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1201 / 11635 (10.3%) | 5291 / 116350 (4.5%) | −129.3 | −127.1 | 2.27 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1476 / 11635 (12.7%) | 7196 / 116350 (6.2%) | −129.0 | −126.8 | 2.05 |
| TCF12 SRX190356 | SK-N-SH Neural | 627 / 11635 (5.4%) | 14312 / 116350 (12.3%) | −128.9 | −126.7 | 0.44 |
| Epitope tags DRX443510 | 293 Kidney | 1041 / 11635 (8.9%) | 4262 / 116350 (3.7%) | −128.3 | −126.1 | 2.44 |
| PRRX1 SRX15235713 | Hs 578T Breast | 256 / 11635 (2.2%) | 8648 / 116350 (7.4%) | −128.2 | −126.0 | 0.30 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 977 / 11635 (8.4%) | 3861 / 116350 (3.3%) | −128.0 | −125.8 | 2.53 |
| RORC SRX5359052 | HCC70 Breast | 945 / 11635 (8.1%) | 3662 / 116350 (3.1%) | −128.0 | −125.8 | 2.58 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1021 / 11635 (8.8%) | 4142 / 116350 (3.6%) | −127.8 | −125.6 | 2.46 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 306 / 11635 (2.6%) | 9443 / 116350 (8.1%) | −127.3 | −125.1 | 0.32 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 162 / 11635 (1.4%) | 6960 / 116350 (6.0%) | −127.2 | −125.0 | 0.23 |
| RORC SRX5359053 | HCC70 Breast | 919 / 11635 (7.9%) | 3519 / 116350 (3.0%) | −126.9 | −124.7 | 2.61 |
| ERG SRX063921 | K-562 Blood | 1072 / 11635 (9.2%) | 4499 / 116350 (3.9%) | −126.3 | −124.1 | 2.38 |
| AR SRX9469988 | LAPC-4 Prostate | 296 / 11635 (2.5%) | 9229 / 116350 (7.9%) | −125.7 | −123.5 | 0.32 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 403 / 11635 (3.5%) | 782 / 116350 (0.7%) | −125.5 | −123.3 | 5.15 |
| ERG SRX063922 | K-562 Blood | 1118 / 11635 (9.6%) | 4820 / 116350 (4.1%) | −125.2 | −123.1 | 2.32 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 87 / 11635 (0.7%) | 5410 / 116350 (4.6%) | −125.1 | −122.9 | 0.16 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 190 / 11635 (1.6%) | 95 / 116350 (0.1%) | −124.8 | −122.7 | 20.00 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 203 / 11635 (1.7%) | 7629 / 116350 (6.6%) | −124.8 | −122.6 | 0.27 |
| FOSL2 SRX190296 | SK-N-SH Neural | 297 / 11635 (2.6%) | 9204 / 116350 (7.9%) | −124.6 | −122.4 | 0.32 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 601 / 11635 (5.2%) | 1729 / 116350 (1.5%) | −124.5 | −122.4 | 3.48 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 787 / 11635 (6.8%) | 2766 / 116350 (2.4%) | −124.3 | −122.1 | 2.85 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 589 / 11635 (5.1%) | 13579 / 116350 (11.7%) | −123.8 | −121.6 | 0.43 |
| RAC1 SRX10365541 | MCF-7 Breast | 99 / 11635 (0.9%) | 5624 / 116350 (4.8%) | −123.6 | −121.4 | 0.18 |
| JUN SRX883584 | MDA-MB-231 Breast | 354 / 11635 (3.0%) | 10076 / 116350 (8.7%) | −123.5 | −121.3 | 0.35 |
| AR SRX1067067 | LHSAR Prostate | 402 / 11635 (3.5%) | 10810 / 116350 (9.3%) | −123.3 | −121.1 | 0.37 |
| AR SRX1067066 | LHSAR Prostate | 497 / 11635 (4.3%) | 12211 / 116350 (10.5%) | −122.8 | −120.7 | 0.41 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 168 / 11635 (1.4%) | 6926 / 116350 (6.0%) | −122.5 | −120.3 | 0.24 |
| ESR1 SRX20282972 | MCF-7 Breast | 259 / 11635 (2.2%) | 8509 / 116350 (7.3%) | −122.4 | −120.2 | 0.30 |
| YAP1 SRX10119364 | MCF 10A Breast | 175 / 11635 (1.5%) | 7050 / 116350 (6.1%) | −122.3 | −120.2 | 0.25 |
| TET2 SRX1427029 | 293 Kidney | 922 / 11635 (7.9%) | 3614 / 116350 (3.1%) | −122.3 | −120.2 | 2.55 |
| ESR1 SRX10365536 | MCF-7 Breast | 104 / 11635 (0.9%) | 5688 / 116350 (4.9%) | −122.3 | −120.1 | 0.18 |
| GRHL3 SRX2582162 | NHEK Epidermis | 773 / 11635 (6.6%) | 2715 / 116350 (2.3%) | −122.1 | −120.0 | 2.85 |
| EP300 SRX2671813 | Fibroblasts Others | 179 / 11635 (1.5%) | 7117 / 116350 (6.1%) | −122.1 | −119.9 | 0.25 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 190 / 11635 (1.6%) | 7310 / 116350 (6.3%) | −122.1 | −119.9 | 0.26 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 677 / 11635 (5.8%) | 14742 / 116350 (12.7%) | −122.0 | −119.9 | 0.46 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 200 / 11635 (1.7%) | 7472 / 116350 (6.4%) | −121.5 | −119.4 | 0.27 |
| JUNB SRX8488074 | SUM 229PE Breast | 301 / 11635 (2.6%) | 9165 / 116350 (7.9%) | −121.4 | −119.3 | 0.33 |
| MethylCap SRX014767 | NB-4 Blood | 1226 / 11635 (10.5%) | 5628 / 116350 (4.8%) | −121.2 | −119.0 | 2.18 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 146 / 11635 (1.3%) | 6477 / 116350 (5.6%) | −121.1 | −119.0 | 0.23 |
| RELA SRX2207672 | HUVEC Cardiovascular | 908 / 11635 (7.8%) | 17808 / 116350 (15.3%) | −120.9 | −118.8 | 0.51 |
| FOXA1 SRX1787652 | MCF-7 Breast | 120 / 11635 (1.0%) | 5967 / 116350 (5.1%) | −120.8 | −118.7 | 0.20 |
| JUND SRX190357 | SK-N-SH Neural | 287 / 11635 (2.5%) | 8913 / 116350 (7.7%) | −120.8 | −118.6 | 0.32 |
| FOXA1 SRX1161174 | MCF-7 Breast | 231 / 11635 (2.0%) | 7983 / 116350 (6.9%) | −120.7 | −118.6 | 0.29 |
| MECOM SRX23677890 | HNT-34 Blood | 1274 / 11635 (10.9%) | 5973 / 116350 (5.1%) | −120.4 | −118.3 | 2.13 |
| FOXA2 SRX3230382 | Hep G2 Liver | 315 / 11635 (2.7%) | 9348 / 116350 (8.0%) | −120.2 | −118.1 | 0.34 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 405 / 11635 (3.5%) | 10737 / 116350 (9.2%) | −120.0 | −117.8 | 0.38 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 305 / 11635 (2.6%) | 9177 / 116350 (7.9%) | −119.9 | −117.7 | 0.33 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 355 / 11635 (3.1%) | 9961 / 116350 (8.6%) | −119.8 | −117.7 | 0.36 |
| JUN SRX6582171 | GM07492 Others | 455 / 11635 (3.9%) | 11481 / 116350 (9.9%) | −119.8 | −117.6 | 0.40 |
| FOXA1 SRX3931043 | MCF-7 Breast | 228 / 11635 (2.0%) | 7898 / 116350 (6.8%) | −119.7 | −117.6 | 0.29 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 862 / 11635 (7.4%) | 3294 / 116350 (2.8%) | −119.1 | −117.0 | 2.62 |
| RAC1 SRX10365543 | MCF-7 Breast | 107 / 11635 (0.9%) | 5653 / 116350 (4.9%) | −118.9 | −116.8 | 0.19 |
| RELA SRX5938177 | FaDu Others | 204 / 11635 (1.8%) | 7451 / 116350 (6.4%) | −118.7 | −116.6 | 0.27 |
| FOXA1 SRX11222441 | MCF-7 Breast | 165 / 11635 (1.4%) | 6755 / 116350 (5.8%) | −118.6 | −116.5 | 0.24 |
| ESR1 SRX20282954 | MCF-7 Breast | 257 / 11635 (2.2%) | 8344 / 116350 (7.2%) | −118.4 | −116.3 | 0.31 |
| FOS SRX3322636 | MCF-7 Breast | 132 / 11635 (1.1%) | 6129 / 116350 (5.3%) | −118.4 | −116.3 | 0.22 |
| NFYB SRX16608147 | HeLa Uterus | 210 / 11635 (1.8%) | 157 / 116350 (0.1%) | −118.4 | −116.3 | 13.38 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 203 / 11635 (1.7%) | 7422 / 116350 (6.4%) | −118.3 | −116.2 | 0.27 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 170 / 11635 (1.5%) | 6828 / 116350 (5.9%) | −118.0 | −115.9 | 0.25 |
| FOXA1 SRX100506 | Hep G2 Liver | 310 / 11635 (2.7%) | 9190 / 116350 (7.9%) | −117.9 | −115.8 | 0.34 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 294 / 11635 (2.5%) | 8931 / 116350 (7.7%) | −117.9 | −115.8 | 0.33 |
| ARID1A SRX5089379 | MCF-7 Breast | 225 / 11635 (1.9%) | 7786 / 116350 (6.7%) | −117.7 | −115.6 | 0.29 |
| CXXC1 SRX1424886 | SEM Blood | 1023 / 11635 (8.8%) | 4339 / 116350 (3.7%) | −117.7 | −115.6 | 2.36 |
| TLE3 SRX4815192 | MCF-7 Breast | 201 / 11635 (1.7%) | 7366 / 116350 (6.3%) | −117.7 | −115.6 | 0.27 |
| JUNB SRX10119383 | MCF 10A Breast | 144 / 11635 (1.2%) | 6332 / 116350 (5.4%) | −117.5 | −115.4 | 0.23 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 212 / 11635 (1.8%) | 7547 / 116350 (6.5%) | −117.4 | −115.3 | 0.28 |
| ESR1 SRX2943591 | MCF-7 Breast | 151 / 11635 (1.3%) | 6455 / 116350 (5.5%) | −117.2 | −115.1 | 0.23 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 163 / 11635 (1.4%) | 6666 / 116350 (5.7%) | −117.0 | −114.9 | 0.24 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 301 / 11635 (2.6%) | 9000 / 116350 (7.7%) | −116.6 | −114.5 | 0.33 |
| ESR1 SRX371477 | MCF-7 Breast | 104 / 11635 (0.9%) | 5522 / 116350 (4.7%) | −116.4 | −114.4 | 0.19 |
| FOXA1 SRX100454 | T-47D Breast | 313 / 11635 (2.7%) | 9181 / 116350 (7.9%) | −116.2 | −114.1 | 0.34 |
| INTS3 SRX3640569 | HeLa Uterus | 899 / 11635 (7.7%) | 3575 / 116350 (3.1%) | −116.1 | −114.1 | 2.51 |
| FOXA1 SRX3931055 | MCF-7 Breast | 189 / 11635 (1.6%) | 7101 / 116350 (6.1%) | −115.9 | −113.8 | 0.27 |
| MECOM SRX23677891 | HNT-34 Blood | 1256 / 11635 (10.8%) | 5959 / 116350 (5.1%) | −115.5 | −113.5 | 2.11 |
| ESR1 SRX20282946 | MCF-7 Breast | 128 / 11635 (1.1%) | 5967 / 116350 (5.1%) | −115.5 | −113.5 | 0.21 |
| MEN1 SRX11712604 | K-562 Blood | 991 / 11635 (8.5%) | 4175 / 116350 (3.6%) | −115.4 | −113.3 | 2.37 |
| NABP2 SRX9523535 | HT-1080 Bone | 964 / 11635 (8.3%) | 4001 / 116350 (3.4%) | −115.4 | −113.3 | 2.41 |
| FOXA1 SRX11222442 | MCF-7 Breast | 146 / 11635 (1.3%) | 6300 / 116350 (5.4%) | −115.2 | −113.1 | 0.23 |
| TEAD1 SRX3401272 | MCF-7 Breast | 173 / 11635 (1.5%) | 6793 / 116350 (5.8%) | −115.1 | −113.1 | 0.25 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 248 / 11635 (2.1%) | 8079 / 116350 (6.9%) | −115.0 | −112.9 | 0.31 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 534 / 11635 (4.6%) | 1489 / 116350 (1.3%) | −114.8 | −112.7 | 3.59 |
| ESR1 SRX371475 | BT-474 Breast | 106 / 11635 (0.9%) | 5508 / 116350 (4.7%) | −114.6 | −112.6 | 0.19 |
| STAT1 SRX23678708 | K-562 Blood | 1060 / 11635 (9.1%) | 4644 / 116350 (4.0%) | −114.6 | −112.5 | 2.28 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 252 / 11635 (2.2%) | 8126 / 116350 (7.0%) | −114.3 | −112.2 | 0.31 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 554 / 11635 (4.8%) | 1601 / 116350 (1.4%) | −114.0 | −112.0 | 3.46 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 223 / 11635 (1.9%) | 7626 / 116350 (6.6%) | −113.9 | −111.9 | 0.29 |
| FOXA1 SRX1787655 | MCF-7 Breast | 102 / 11635 (0.9%) | 5404 / 116350 (4.6%) | −113.7 | −111.6 | 0.19 |
| STAT3 SRX150479 | MCF 10A Breast | 212 / 11635 (1.8%) | 7429 / 116350 (6.4%) | −113.6 | −111.5 | 0.29 |
| FOXA1 SRX3923514 | MCF-7 Breast | 241 / 11635 (2.1%) | 7916 / 116350 (6.8%) | −113.6 | −111.5 | 0.30 |
| EP300 SRX2194265 | SUM 159PT Breast | 382 / 11635 (3.3%) | 10153 / 116350 (8.7%) | −113.4 | −111.4 | 0.38 |
| JUNB SRX10119384 | MCF 10A Breast | 129 / 11635 (1.1%) | 5927 / 116350 (5.1%) | −113.4 | −111.4 | 0.22 |
| FOXA1 SRX11222437 | MCF-7 Breast | 160 / 11635 (1.4%) | 6499 / 116350 (5.6%) | −113.3 | −111.2 | 0.25 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 231 / 11635 (2.0%) | 7742 / 116350 (6.7%) | −113.2 | −111.2 | 0.30 |
| CEBPA SRX2630241 | Hep G2 Liver | 289 / 11635 (2.5%) | 8693 / 116350 (7.5%) | −113.2 | −111.2 | 0.33 |
| FOXA2 SRX100448 | Hep G2 Liver | 266 / 11635 (2.3%) | 8317 / 116350 (7.1%) | −113.0 | −111.0 | 0.32 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1323 / 11635 (11.4%) | 6489 / 116350 (5.6%) | −113.0 | −111.0 | 2.04 |
| ESR1 SRX10365532 | MCF-7 Breast | 116 / 11635 (1.0%) | 5658 / 116350 (4.9%) | −112.9 | −110.8 | 0.21 |
| DAXX SRX1021630 | PC-3 Prostate | 237 / 11635 (2.0%) | 7826 / 116350 (6.7%) | −112.8 | −110.8 | 0.30 |
| KAT7 DRX234808 | 293 Kidney | 547 / 11635 (4.7%) | 1578 / 116350 (1.4%) | −112.8 | −110.8 | 3.47 |
| JADE3 DRX300415 | 293 Kidney | 1050 / 11635 (9.0%) | 4622 / 116350 (4.0%) | −112.4 | −110.4 | 2.27 |
| FOXA1 SRX5323843 | MCF-7 Breast | 110 / 11635 (0.9%) | 5526 / 116350 (4.7%) | −112.4 | −110.4 | 0.20 |
| ESR1 SRX20282940 | MCF-7 Breast | 266 / 11635 (2.3%) | 8289 / 116350 (7.1%) | −112.4 | −110.3 | 0.32 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 427 / 11635 (3.7%) | 10789 / 116350 (9.3%) | −112.3 | −110.3 | 0.40 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 312 / 11635 (2.7%) | 9026 / 116350 (7.8%) | −112.3 | −110.2 | 0.35 |
| EP300 SRX150579 | HeLa Uterus | 147 / 11635 (1.3%) | 6227 / 116350 (5.4%) | −112.2 | −110.2 | 0.24 |
| ESR1 SRX20282973 | MCF-7 Breast | 297 / 11635 (2.6%) | 8784 / 116350 (7.5%) | −112.2 | −110.2 | 0.34 |
| CDK9 SRX7366781 | MCF-7 Breast | 181 / 11635 (1.6%) | 107 / 116350 (0.1%) | −112.2 | −110.2 | 16.92 |
| FOXA1 SRX3931054 | MCF-7 Breast | 222 / 11635 (1.9%) | 7545 / 116350 (6.5%) | −111.9 | −109.9 | 0.29 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 880 / 11635 (7.6%) | 3528 / 116350 (3.0%) | −111.9 | −109.9 | 2.49 |
| PGR SRX1012655 | MCF-7 Breast | 141 / 11635 (1.2%) | 6109 / 116350 (5.3%) | −111.9 | −109.9 | 0.23 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 387 / 11635 (3.3%) | 10173 / 116350 (8.7%) | −111.9 | −109.9 | 0.38 |
| NR3C1 SRX2609664 | HASM2 Lung | 343 / 11635 (2.9%) | 9499 / 116350 (8.2%) | −111.9 | −109.9 | 0.36 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 221 / 11635 (1.9%) | 7523 / 116350 (6.5%) | −111.8 | −109.8 | 0.29 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 567 / 11635 (4.9%) | 12798 / 116350 (11.0%) | −111.8 | −109.8 | 0.44 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 193 / 11635 (1.7%) | 7037 / 116350 (6.0%) | −111.6 | −109.6 | 0.27 |
| ARID1A SRX5089385 | MCF-7 Breast | 172 / 11635 (1.5%) | 6652 / 116350 (5.7%) | −111.2 | −109.2 | 0.26 |
| JUN SRX6582172 | Fibroblasts Others | 315 / 11635 (2.7%) | 9037 / 116350 (7.8%) | −111.2 | −109.1 | 0.35 |
| FOXA1 SRX1787651 | MCF-7 Breast | 123 / 11635 (1.1%) | 5740 / 116350 (4.9%) | −111.1 | −109.1 | 0.21 |
| NR3C1 SRX17639412 | A549 Lung | 271 / 11635 (2.3%) | 8329 / 116350 (7.2%) | −111.0 | −109.0 | 0.33 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 208 / 11635 (1.8%) | 7262 / 116350 (6.2%) | −110.6 | −108.5 | 0.29 |
| GATA3 SRX5457550 | MCF-7 Breast | 271 / 11635 (2.3%) | 8308 / 116350 (7.1%) | −110.5 | −108.5 | 0.33 |
| FOXA1 SRX1447317 | MCF-7 Breast | 148 / 11635 (1.3%) | 6196 / 116350 (5.3%) | −110.5 | −108.5 | 0.24 |
| ESR1 SRX371474 | BT-474 Breast | 99 / 11635 (0.9%) | 5249 / 116350 (4.5%) | −110.5 | −108.5 | 0.19 |
| JUND SRX150408 | HeLa Uterus | 207 / 11635 (1.8%) | 7238 / 116350 (6.2%) | −110.3 | −108.3 | 0.29 |
| PBX3 SRX190343 | SK-N-SH Neural | 519 / 11635 (4.5%) | 12042 / 116350 (10.3%) | −110.0 | −108.0 | 0.43 |
| EP300 SRX2194266 | SUM 159PT Breast | 433 / 11635 (3.7%) | 10785 / 116350 (9.3%) | −109.8 | −107.8 | 0.40 |
| CHD6 SRX17709200 | C4-2 Prostate | 1088 / 11635 (9.4%) | 4930 / 116350 (4.2%) | −109.8 | −107.8 | 2.21 |
| FOXL2 SRX6957431 | KGN Gonad | 570 / 11635 (4.9%) | 12760 / 116350 (11.0%) | −109.8 | −107.8 | 0.45 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 223 / 11635 (1.9%) | 7490 / 116350 (6.4%) | −109.8 | −107.8 | 0.30 |
| NKX2-1 SRX2164786 | A549 Lung | 408 / 11635 (3.5%) | 10410 / 116350 (8.9%) | −109.8 | −107.8 | 0.39 |
| NR2F2 SRX190293 | MCF-7 Breast | 255 / 11635 (2.2%) | 8025 / 116350 (6.9%) | −109.7 | −107.7 | 0.32 |
| STAT3 SRX150630 | MCF 10A Breast | 217 / 11635 (1.9%) | 7387 / 116350 (6.3%) | −109.7 | −107.7 | 0.29 |
| FOSL2 SRX190204 | A549 Lung | 236 / 11635 (2.0%) | 7702 / 116350 (6.6%) | −109.6 | −107.6 | 0.31 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 433 / 11635 (3.7%) | 10773 / 116350 (9.3%) | −109.5 | −107.5 | 0.40 |
| ESR1 SRX4367192 | MCF-7 Breast | 511 / 11635 (4.4%) | 11911 / 116350 (10.2%) | −109.5 | −107.5 | 0.43 |
| TLE3 SRX4815194 | SUM 149PT Breast | 179 / 11635 (1.5%) | 6720 / 116350 (5.8%) | −109.3 | −107.3 | 0.27 |
| JUN SRX2355072 | HAEC Cardiovascular | 322 / 11635 (2.8%) | 9073 / 116350 (7.8%) | −109.1 | −107.2 | 0.35 |
| WWTR1 SRX10119367 | MCF 10A Breast | 288 / 11635 (2.5%) | 8534 / 116350 (7.3%) | −109.1 | −107.1 | 0.34 |
| FOXA1 SRX028634 | MCF-7 Breast | 105 / 11635 (0.9%) | 5326 / 116350 (4.6%) | −109.0 | −107.0 | 0.20 |
| CDK9 SRX7366783 | MCF-7 Breast | 182 / 11635 (1.6%) | 118 / 116350 (0.1%) | −108.9 | −106.9 | 15.42 |
| FOS SRX070879 | HUVEC Cardiovascular | 253 / 11635 (2.2%) | 7950 / 116350 (6.8%) | −108.5 | −106.5 | 0.32 |
| ESR1 SRX10365535 | MCF-7 Breast | 197 / 11635 (1.7%) | 7001 / 116350 (6.0%) | −108.4 | −106.4 | 0.28 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 845 / 11635 (7.3%) | 3370 / 116350 (2.9%) | −108.4 | −106.4 | 2.51 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1091 / 11635 (9.4%) | 4982 / 116350 (4.3%) | −108.3 | −106.4 | 2.19 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 146 / 11635 (1.3%) | 6088 / 116350 (5.2%) | −108.2 | −106.3 | 0.24 |
| ZEB1 SRX13298925 | MCF-7 Breast | 140 / 11635 (1.2%) | 5979 / 116350 (5.1%) | −108.2 | −106.3 | 0.23 |
| PROX1 SRX3230397 | Hep G2 Liver | 168 / 11635 (1.4%) | 6488 / 116350 (5.6%) | −108.1 | −106.2 | 0.26 |
| ZFX SRX7805370 | 293 Kidney | 783 / 11635 (6.7%) | 3001 / 116350 (2.6%) | −107.4 | −105.4 | 2.61 |
| EP300 SRX1012648 | MCF-7 Breast | 104 / 11635 (0.9%) | 5254 / 116350 (4.5%) | −107.2 | −105.2 | 0.20 |
| ESR1 SRX20282955 | MCF-7 Breast | 267 / 11635 (2.3%) | 8129 / 116350 (7.0%) | −107.1 | −105.1 | 0.33 |
| AFF1 SRX2281250 | SEM Blood | 673 / 11635 (5.8%) | 2351 / 116350 (2.0%) | −106.9 | −104.9 | 2.86 |
| JUN SRX7277180 | GM07492 Others | 199 / 11635 (1.7%) | 6990 / 116350 (6.0%) | −106.8 | −104.9 | 0.28 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 168 / 11635 (1.4%) | 6443 / 116350 (5.5%) | −106.8 | −104.9 | 0.26 |
| SSRP1 SRX3436566 | HT-1080 Bone | 230 / 11635 (2.0%) | 254 / 116350 (0.2%) | −106.7 | −104.7 | 9.06 |
| ESR1 SRX8537722 | MCF-7 Breast | 228 / 11635 (2.0%) | 7469 / 116350 (6.4%) | −106.5 | −104.6 | 0.31 |
| EP300 SRX176885 | MCF-7 Breast | 115 / 11635 (1.0%) | 5449 / 116350 (4.7%) | −106.5 | −104.5 | 0.21 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 321 / 11635 (2.8%) | 8964 / 116350 (7.7%) | −106.5 | −104.5 | 0.36 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 431 / 11635 (3.7%) | 10623 / 116350 (9.1%) | −106.2 | −104.3 | 0.41 |
| ESR1 SRX1012632 | MCF-7 Breast | 112 / 11635 (1.0%) | 5377 / 116350 (4.6%) | −106.0 | −104.1 | 0.21 |
| ARID1A SRX5089391 | MCF-7 Breast | 125 / 11635 (1.1%) | 5627 / 116350 (4.8%) | −106.0 | −104.0 | 0.22 |
| GATAD2A SRX2636506 | Hep G2 Liver | 320 / 11635 (2.8%) | 8928 / 116350 (7.7%) | −105.9 | −104.0 | 0.36 |
| GRHL3 SRX2582161 | NHEK Epidermis | 639 / 11635 (5.5%) | 2169 / 116350 (1.9%) | −105.9 | −103.9 | 2.95 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 461 / 11635 (4.0%) | 11031 / 116350 (9.5%) | −105.4 | −103.5 | 0.42 |
| NR3C1 SRX10976921 | A549 Lung | 171 / 11635 (1.5%) | 6452 / 116350 (5.5%) | −105.4 | −103.4 | 0.27 |
| SREBF2 SRX5359049 | HCC70 Breast | 826 / 11635 (7.1%) | 3303 / 116350 (2.8%) | −105.3 | −103.4 | 2.50 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 247 / 11635 (2.1%) | 7742 / 116350 (6.7%) | −105.3 | −103.3 | 0.32 |
| STAT3 SRX2020842 | HCC70 Breast | 458 / 11635 (3.9%) | 10979 / 116350 (9.4%) | −105.2 | −103.3 | 0.42 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1097 / 11635 (9.4%) | 5092 / 116350 (4.4%) | −105.2 | −103.2 | 2.15 |
| FOXA1 SRX11222438 | MCF-7 Breast | 121 / 11635 (1.0%) | 5524 / 116350 (4.7%) | −105.1 | −103.2 | 0.22 |
| MethylCap SRX014766 | NB-4 Blood | 1070 / 11635 (9.2%) | 4910 / 116350 (4.2%) | −105.1 | −103.1 | 2.18 |
| KMT2A SRX2281249 | SEM Blood | 1308 / 11635 (11.2%) | 6574 / 116350 (5.7%) | −105.1 | −103.1 | 1.99 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 490 / 11635 (4.2%) | 11431 / 116350 (9.8%) | −105.0 | −103.0 | 0.43 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 77 / 11635 (0.7%) | 4638 / 116350 (4.0%) | −105.0 | −103.0 | 0.17 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 337 / 11635 (2.9%) | 9157 / 116350 (7.9%) | −104.9 | −103.0 | 0.37 |
| GATA3 SRX6712581 | MCF-7 Breast | 199 / 11635 (1.7%) | 6924 / 116350 (6.0%) | −104.8 | −102.9 | 0.29 |
| ESR1 SRX330067 | MCF-7 Breast | 228 / 11635 (2.0%) | 7412 / 116350 (6.4%) | −104.8 | −102.9 | 0.31 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 336 / 11635 (2.9%) | 9139 / 116350 (7.9%) | −104.8 | −102.9 | 0.37 |
| ESR1 SRX2881002 | MCF-7 Breast | 239 / 11635 (2.1%) | 7591 / 116350 (6.5%) | −104.7 | −102.8 | 0.31 |
| ESR1 SRX20282938 | MCF-7 Breast | 201 / 11635 (1.7%) | 6949 / 116350 (6.0%) | −104.6 | −102.7 | 0.29 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 357 / 11635 (3.1%) | 9450 / 116350 (8.1%) | −104.6 | −102.7 | 0.38 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 407 / 11635 (3.5%) | 966 / 116350 (0.8%) | −104.6 | −102.6 | 4.21 |
| FOXA1 SRX100477 | Hep G2 Liver | 290 / 11635 (2.5%) | 8409 / 116350 (7.2%) | −104.6 | −102.6 | 0.34 |
| Epitope tags SRX10715360 | HCB1 Blood | 772 / 11635 (6.6%) | 2980 / 116350 (2.6%) | −104.5 | −102.6 | 2.59 |
| HMG20A SRX2630163 | Hep G2 Liver | 132 / 11635 (1.1%) | 5716 / 116350 (4.9%) | −104.5 | −102.6 | 0.23 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 112 / 11635 (1.0%) | 5334 / 116350 (4.6%) | −104.5 | −102.5 | 0.21 |
| JUN SRX6582163 | BJ-5ta Epidermis | 313 / 11635 (2.7%) | 8767 / 116350 (7.5%) | −104.4 | −102.5 | 0.36 |
| ESR1 SRX2881000 | MCF-7 Breast | 220 / 11635 (1.9%) | 7263 / 116350 (6.2%) | −104.3 | −102.4 | 0.30 |
| PHF6 SRX11508321 | G-401 Kidney | 1047 / 11635 (9.0%) | 4774 / 116350 (4.1%) | −104.1 | −102.1 | 2.19 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 288 / 11635 (2.5%) | 8359 / 116350 (7.2%) | −104.0 | −102.1 | 0.34 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 157 / 11635 (1.3%) | 6156 / 116350 (5.3%) | −103.9 | −102.0 | 0.26 |
| ESR1 SRX4451213 | MCF-7 Breast | 257 / 11635 (2.2%) | 7853 / 116350 (6.7%) | −103.7 | −101.8 | 0.33 |
| ESR1 SRX2912055 | MCF-7 Breast | 85 / 11635 (0.7%) | 4768 / 116350 (4.1%) | −103.6 | −101.7 | 0.18 |
| Epitope tags SRX10549777 | K-562 Blood | 1631 / 11635 (14.0%) | 9008 / 116350 (7.7%) | −103.5 | −101.6 | 1.81 |
| FOXA1 SRX6878603 | LNCAP Prostate | 274 / 11635 (2.4%) | 8119 / 116350 (7.0%) | −103.4 | −101.5 | 0.34 |
| CEBPA SRX4705113 | MOLM-13 Blood | 604 / 11635 (5.2%) | 12965 / 116350 (11.1%) | −103.1 | −101.2 | 0.47 |
| CHD6 SRX17709201 | C4-2 Prostate | 1041 / 11635 (8.9%) | 4754 / 116350 (4.1%) | −103.1 | −101.2 | 2.19 |
| SOX13 SRX2636248 | Hep G2 Liver | 355 / 11635 (3.1%) | 9362 / 116350 (8.0%) | −103.0 | −101.1 | 0.38 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 94 / 11635 (0.8%) | 4923 / 116350 (4.2%) | −102.6 | −100.7 | 0.19 |
| ESR1 SRX1012633 | MCF-7 Breast | 121 / 11635 (1.0%) | 5448 / 116350 (4.7%) | −102.6 | −100.6 | 0.22 |
| FOXA1 SRX5203303 | MCF-7 Breast | 74 / 11635 (0.6%) | 4501 / 116350 (3.9%) | −102.4 | −100.5 | 0.16 |
| ESR1 SRX3110725 | MCF-7 Breast | 229 / 11635 (2.0%) | 7350 / 116350 (6.3%) | −102.4 | −100.5 | 0.31 |
| FOXA1 SRX028635 | MCF-7 Breast | 119 / 11635 (1.0%) | 5409 / 116350 (4.6%) | −102.4 | −100.5 | 0.22 |
| NR3C1 SRX19024866 | MCF-7 Breast | 76 / 11635 (0.7%) | 4540 / 116350 (3.9%) | −102.3 | −100.4 | 0.17 |
| ESR1 SRX20282971 | MCF-7 Breast | 256 / 11635 (2.2%) | 7786 / 116350 (6.7%) | −102.2 | −100.3 | 0.33 |
| AR SRX9109110 | MDA-MB-453 Breast | 488 / 11635 (4.2%) | 11292 / 116350 (9.7%) | −102.1 | −100.2 | 0.43 |
| ESR1 SRX330070 | MCF-7 Breast | 125 / 11635 (1.1%) | 5508 / 116350 (4.7%) | −102.1 | −100.2 | 0.23 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 376 / 11635 (3.2%) | 9643 / 116350 (8.3%) | −102.0 | −100.1 | 0.39 |
| FOS SRX3322637 | MCF-7 Breast | 126 / 11635 (1.1%) | 5527 / 116350 (4.8%) | −102.0 | −100.1 | 0.23 |
| ESR1 SRX10365533 | MCF-7 Breast | 110 / 11635 (0.9%) | 5220 / 116350 (4.5%) | −101.9 | −100.0 | 0.21 |
| JUNB SRX10119385 | MCF 10A Breast | 105 / 11635 (0.9%) | 5112 / 116350 (4.4%) | −101.7 | −99.8 | 0.21 |
| JUND SRX699738 | HCASMC Cardiovascular | 360 / 11635 (3.1%) | 9386 / 116350 (8.1%) | −101.5 | −99.6 | 0.38 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 185 / 11635 (1.6%) | 6572 / 116350 (5.6%) | −101.3 | −99.5 | 0.28 |
| SMARCA4 SRX5982340 | A549 Lung | 92 / 11635 (0.8%) | 4846 / 116350 (4.2%) | −101.3 | −99.4 | 0.19 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 225 / 11635 (1.9%) | 7243 / 116350 (6.2%) | −101.3 | −99.4 | 0.31 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 386 / 11635 (3.3%) | 9768 / 116350 (8.4%) | −101.2 | −99.3 | 0.40 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 240 / 11635 (2.1%) | 7493 / 116350 (6.4%) | −101.2 | −99.3 | 0.32 |
| MED1 SRX5236337 | HUVEC Cardiovascular | 395 / 11635 (3.4%) | 941 / 116350 (0.8%) | −101.1 | −99.2 | 4.20 |
| ESR1 SRX1531796 | MCF-7 Breast | 129 / 11635 (1.1%) | 5550 / 116350 (4.8%) | −101.0 | −99.1 | 0.23 |
| STAT3 SRX150536 | MCF 10A Breast | 285 / 11635 (2.4%) | 8201 / 116350 (7.0%) | −100.8 | −98.9 | 0.35 |
| FOXA1 SRX1161203 | T-47D Breast | 175 / 11635 (1.5%) | 6371 / 116350 (5.5%) | −100.6 | −98.8 | 0.27 |
| ESR1 SRX2943589 | MCF-7 Breast | 121 / 11635 (1.0%) | 5391 / 116350 (4.6%) | −100.6 | −98.7 | 0.22 |
| ESR1 SRX330069 | MCF-7 Breast | 154 / 11635 (1.3%) | 6000 / 116350 (5.2%) | −100.6 | −98.7 | 0.26 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 168 / 11635 (1.4%) | 6246 / 116350 (5.4%) | −100.5 | −98.7 | 0.27 |
| WWTR1 SRX10119378 | MCF 10A Breast | 284 / 11635 (2.4%) | 8174 / 116350 (7.0%) | −100.5 | −98.7 | 0.35 |
| Crotonyllysine SRX12306536 | Polycystic kidney Kidney | 1044 / 11635 (9.0%) | 4831 / 116350 (4.2%) | −100.5 | −98.6 | 2.16 |
| NR3C1 SRX10977372 | A549 Lung | 144 / 11635 (1.2%) | 5815 / 116350 (5.0%) | −100.5 | −98.6 | 0.25 |
| SP1 SRX190358 | HCT 116 Digestive tract | 399 / 11635 (3.4%) | 9924 / 116350 (8.5%) | −100.3 | −98.5 | 0.40 |
| ARID5B SRX3230377 | Hep G2 Liver | 656 / 11635 (5.6%) | 13558 / 116350 (11.7%) | −100.3 | −98.4 | 0.48 |
| ESR1 SRX20282953 | MCF-7 Breast | 213 / 11635 (1.8%) | 7008 / 116350 (6.0%) | −100.1 | −98.3 | 0.30 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 757 / 11635 (6.5%) | 14899 / 116350 (12.8%) | −99.9 | −98.0 | 0.51 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 208 / 11635 (1.8%) | 6914 / 116350 (5.9%) | −99.9 | −98.0 | 0.30 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 211 / 11635 (1.8%) | 6962 / 116350 (6.0%) | −99.8 | −97.9 | 0.30 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1135 / 11635 (9.8%) | 5479 / 116350 (4.7%) | −99.7 | −97.8 | 2.07 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1026 / 11635 (8.8%) | 4728 / 116350 (4.1%) | −99.6 | −97.8 | 2.17 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 374 / 11635 (3.2%) | 9525 / 116350 (8.2%) | −99.6 | −97.8 | 0.39 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1527 / 11635 (13.1%) | 8338 / 116350 (7.2%) | −99.6 | −97.7 | 1.83 |
| ING2 SRX286201 | RKO Digestive tract | 940 / 11635 (8.1%) | 4150 / 116350 (3.6%) | −99.6 | −97.7 | 2.27 |
| TFAP2C SRX128099 | MCF-7 Breast | 234 / 11635 (2.0%) | 7334 / 116350 (6.3%) | −99.5 | −97.7 | 0.32 |
| TFAP2C SRX018833 | MCF-7 Breast | 234 / 11635 (2.0%) | 7336 / 116350 (6.3%) | −99.5 | −97.7 | 0.32 |
| Epitope tags SRX2255894 | 293 Kidney | 906 / 11635 (7.8%) | 3926 / 116350 (3.4%) | −99.5 | −97.6 | 2.31 |
| JADE3 DRX234809 | 293 Kidney | 688 / 11635 (5.9%) | 2550 / 116350 (2.2%) | −99.5 | −97.6 | 2.70 |
| FOXA1 SRX3931033 | MCF-7 Breast | 160 / 11635 (1.4%) | 6066 / 116350 (5.2%) | −99.4 | −97.5 | 0.26 |
| JUN SRX6582164 | BJ-5ta Epidermis | 330 / 11635 (2.8%) | 8845 / 116350 (7.6%) | −99.2 | −97.3 | 0.37 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1125 / 11635 (9.7%) | 5424 / 116350 (4.7%) | −99.1 | −97.2 | 2.07 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 143 / 11635 (1.2%) | 61 / 116350 (0.1%) | −98.9 | −97.0 | 23.44 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 381 / 11635 (3.3%) | 9604 / 116350 (8.3%) | −98.8 | −97.0 | 0.40 |
| NR3C1 SRX10977373 | A549 Lung | 136 / 11635 (1.2%) | 5616 / 116350 (4.8%) | −98.8 | −96.9 | 0.24 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 207 / 11635 (1.8%) | 6858 / 116350 (5.9%) | −98.8 | −96.9 | 0.30 |
| ESR1 SRX1012629 | MCF-7 Breast | 161 / 11635 (1.4%) | 6063 / 116350 (5.2%) | −98.7 | −96.9 | 0.27 |
| RBFOX2 SRX4708082 | K-562 Blood | 1566 / 11635 (13.5%) | 8661 / 116350 (7.4%) | −98.6 | −96.8 | 1.81 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 338 / 11635 (2.9%) | 8946 / 116350 (7.7%) | −98.6 | −96.8 | 0.38 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 578 / 11635 (5.0%) | 1922 / 116350 (1.7%) | −98.5 | −96.7 | 3.01 |
| FOXA1 SRX3923517 | MCF-7 Breast | 181 / 11635 (1.6%) | 6403 / 116350 (5.5%) | −98.4 | −96.5 | 0.28 |
| ESR1 SRX1469949 | MCF-7 Breast | 147 / 11635 (1.3%) | 5802 / 116350 (5.0%) | −98.4 | −96.5 | 0.25 |
| NR3C1 SRX10977357 | A549 Lung | 158 / 11635 (1.4%) | 6000 / 116350 (5.2%) | −98.3 | −96.4 | 0.26 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 221 / 11635 (1.9%) | 7068 / 116350 (6.1%) | −98.0 | −96.1 | 0.31 |
| EP300 SRX100540 | SK-N-SH Neural | 390 / 11635 (3.4%) | 9706 / 116350 (8.3%) | −98.0 | −96.1 | 0.40 |
| ESR1 SRX3123829 | MCF-7 Breast | 148 / 11635 (1.3%) | 5811 / 116350 (5.0%) | −98.0 | −96.1 | 0.25 |
| FOXA1 SRX15430999 | T-47D Breast | 293 / 11635 (2.5%) | 8228 / 116350 (7.1%) | −98.0 | −96.1 | 0.36 |
| FOXA1 SRX5323829 | T-47D Breast | 138 / 11635 (1.2%) | 5623 / 116350 (4.8%) | −97.9 | −96.1 | 0.25 |
| FOXA1 SRX190181 | A549 Lung | 182 / 11635 (1.6%) | 6406 / 116350 (5.5%) | −97.9 | −96.1 | 0.28 |
| EP300 SRX1012643 | MCF-7 Breast | 85 / 11635 (0.7%) | 4601 / 116350 (4.0%) | −97.8 | −96.0 | 0.18 |
| FOXA1 SRX6878604 | LNCAP Prostate | 205 / 11635 (1.8%) | 6797 / 116350 (5.8%) | −97.8 | −96.0 | 0.30 |
| EP300 SRX1012644 | MCF-7 Breast | 110 / 11635 (0.9%) | 5097 / 116350 (4.4%) | −97.8 | −95.9 | 0.22 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 381 / 11635 (3.3%) | 9554 / 116350 (8.2%) | −97.6 | −95.7 | 0.40 |
| CBFB SRX265218 | ME-1 Blood | 994 / 11635 (8.5%) | 4555 / 116350 (3.9%) | −97.5 | −95.7 | 2.18 |
| FOXA1 SRX3923518 | MCF-7 Breast | 177 / 11635 (1.5%) | 6303 / 116350 (5.4%) | −97.4 | −95.5 | 0.28 |
| EP300 SRX717859 | HeLa Uterus | 129 / 11635 (1.1%) | 5441 / 116350 (4.7%) | −97.4 | −95.5 | 0.24 |
| FOXL2 SRX6957477 | KGN Gonad | 270 / 11635 (2.3%) | 7844 / 116350 (6.7%) | −97.4 | −95.5 | 0.34 |
| ESR1 SRX20282959 | MCF-7 Breast | 101 / 11635 (0.9%) | 4907 / 116350 (4.2%) | −97.3 | −95.5 | 0.21 |
| ESR1 SRX5323878 | MCF-7 Breast | 265 / 11635 (2.3%) | 7759 / 116350 (6.7%) | −97.3 | −95.4 | 0.34 |
| AR SRX15946405 | MDA-MB-453 Breast | 165 / 11635 (1.4%) | 6088 / 116350 (5.2%) | −97.2 | −95.4 | 0.27 |
| FOXA1 SRX190282 | A549 Lung | 178 / 11635 (1.5%) | 6315 / 116350 (5.4%) | −97.2 | −95.4 | 0.28 |
| STAT1 SRX23678707 | K-562 Blood | 953 / 11635 (8.2%) | 4285 / 116350 (3.7%) | −97.2 | −95.4 | 2.22 |
| FOS SRX150664 | HUVEC Cardiovascular | 347 / 11635 (3.0%) | 9031 / 116350 (7.8%) | −97.2 | −95.3 | 0.38 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 272 / 11635 (2.3%) | 7862 / 116350 (6.8%) | −97.1 | −95.3 | 0.35 |
| FOXA1 SRX5203294 | MCF-7 Breast | 65 / 11635 (0.6%) | 4155 / 116350 (3.6%) | −97.0 | −95.2 | 0.16 |
| ARID1A SRX5089382 | MCF-7 Breast | 180 / 11635 (1.5%) | 6343 / 116350 (5.5%) | −97.0 | −95.1 | 0.28 |
| FOXA1 SRX1787654 | MCF-7 Breast | 85 / 11635 (0.7%) | 4571 / 116350 (3.9%) | −96.7 | −94.9 | 0.19 |
| FOXA1 SRX3923516 | MCF-7 Breast | 188 / 11635 (1.6%) | 6471 / 116350 (5.6%) | −96.7 | −94.8 | 0.29 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 855 / 11635 (7.3%) | 3647 / 116350 (3.1%) | −96.6 | −94.7 | 2.34 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 147 / 11635 (1.3%) | 74 / 116350 (0.1%) | −96.5 | −94.7 | 19.86 |
| NANOG SRX10445309 | Neural crest cells Neural | 141 / 11635 (1.2%) | 5639 / 116350 (4.8%) | −96.5 | −94.7 | 0.25 |
| EP300 SRX22550927 | CDS1 Bone | 402 / 11635 (3.5%) | 9826 / 116350 (8.4%) | −96.5 | −94.6 | 0.41 |
| FOXA1 SRX5323845 | MCF-7 Breast | 86 / 11635 (0.7%) | 4583 / 116350 (3.9%) | −96.4 | −94.6 | 0.19 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 479 / 11635 (4.1%) | 10937 / 116350 (9.4%) | −96.4 | −94.6 | 0.44 |
| NR3C1 SRX2609665 | HASM2 Lung | 299 / 11635 (2.6%) | 8260 / 116350 (7.1%) | −96.3 | −94.4 | 0.36 |
| AR SRX11149848 | MDA-MB-453 Breast | 167 / 11635 (1.4%) | 6091 / 116350 (5.2%) | −96.3 | −94.4 | 0.27 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 164 / 11635 (1.4%) | 6041 / 116350 (5.2%) | −96.2 | −94.4 | 0.27 |
| SMARCA4 SRX5982341 | A549 Lung | 70 / 11635 (0.6%) | 4243 / 116350 (3.6%) | −96.2 | −94.4 | 0.16 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 173 / 11635 (1.5%) | 6192 / 116350 (5.3%) | −96.1 | −94.3 | 0.28 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 113 / 11635 (1.0%) | 5098 / 116350 (4.4%) | −96.0 | −94.2 | 0.22 |
| ESR1 SRX8537723 | MCF-7 Breast | 214 / 11635 (1.8%) | 6885 / 116350 (5.9%) | −95.9 | −94.1 | 0.31 |
| AR SRX9109113 | MDA-MB-453 Breast | 518 / 11635 (4.5%) | 11469 / 116350 (9.9%) | −95.9 | −94.1 | 0.45 |
Showing first 500 of 16789 rows.